Pharmaceuticals announced the launch of a new patient access program, in partnership with Direct Relief, to supply inhalers to ...

Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinicsThe program, ...

a Adapted from Fromer L, Goodwin E, Walsh J. Customizing inhaled therapy to meet the needs of COPD patients. Postgrad Med. 2010; 122:83–93, updated using U.S. Food and Drug Administration.

In late 2023, Teva filed a complaint for patent infringement in response to Amneal’s ANDA filing seeking to make and sell a generic version of ProAir HFA (albuterol sulfate) Inhalation Aerosol ...